Sjogren's disease is being researched in terms of its clinical features, pathogenesis, and relevance to clinical trials. The condition is associated with various aspects, including peripheral neuropathy, comorbidities, and mortality, and its management may involve emerging therapies and daily habits. Research and developments, such as cell therapy, are underway to address the disease, with some treatments receiving designations like FDA Fast Track.